Cargando…
Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
The COVID-19 pandemic, caused by the rapid global spread of the novel coronavirus (SARS-CoV-2), has caused healthcare systems to collapse and led to hundreds of thousands of deaths. The clinical spectrum of COVID-19 is not only limited to local pneumonia but also represents multiple organ involvemen...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314259/ https://www.ncbi.nlm.nih.gov/pubmed/34315546 http://dx.doi.org/10.1186/s13287-021-02502-7 |